A Friable Lesion on the Neck of a 15-year-old Boy: Dx?

News
Poll

Video: The lesion bleeds easily and grows back quickly when "knocked off."

A 15-year-old boy presents with a friable, rapidly-growing skin lesion that bleeds easily. It has been present for approximately 3 weeks. Video provides a close-up during examination.

 

What’s your diagnosis?

A. Pyogenic granuloma
B. Hemangioma
C. Carcinoma of the skin
D. Abscess

Newsletter

Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

Subscribe Now!
Related Content
Investigational Oral IL-23 Receptor Antagonist Icotrokinra Improves Skin Clearance in Psoriasis in Phase 3 Study / image credit Robert Bissonnette, MD, International Eczema Council

Investigational Oral IL-23 Receptor Antagonist Icotrokinra Improves Skin Clearance in Psoriasis in Phase 3 Study

Grace Halsey
August 15th 2025
Article
The Weekly Dose: Pediatric Vaccine Safety, Atopic Dermatitis, Dementia Risk, and Maternal Depression

The Weekly Dose: Pediatric Vaccine Safety, Atopic Dermatitis, Dementia Risk, and Maternal Depression

Sydney Jennings
August 15th 2025
Podcast
FDA Approves Delgocitinib, First Treatment for Adults with Moderate to Severe Chronic Hand Eczema / image credit ©Waldenmarus/Shutterstock.com

FDA Approves Delgocitinib, First Treatment for Adults With Moderate to Severe Chronic Hand Eczema

Grace Halsey
August 15th 2025
Article
The Weekly Dose: Clinical Updates on Cancer Detection, Cognitive Screening, CVD Prevention, Atopic Dermatitis Treatment

The Weekly Dose: Clinical Updates on Cancer Detection, Cognitive Screening, CVD Prevention, Atopic Dermatitis Treatment

Sydney Jennings
August 15th 2025
Podcast
Lebrikizumab Maintains Skin Clearance Through 3 Years in AD Patients: Daily Dose / image credit: ©New Africa/AdobeStock

Lebrikizumab Maintains Skin Clearance Through 3 Years in AD Patients: Daily Dose

Sydney Jennings
August 15th 2025
Article
Dupilumab Sustains Long-Term Reduction of S. aureus in People with AD: Daily Dose / image credit: ©New Africa/AdobeStock

Dupilumab Sustains Long-Term Reduction of S. aureus in People with AD: Daily Dose

Sydney Jennings
August 15th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.